Top Markets
Coin of the day
Amniotics AB (publ) Amniotics AB (publ)

Amniotics AB (publ)

AMNI
Rank in Stocks #37511
Amniotics AB (publ) specializes in the creation, manufacturing, and... Amniotics AB (publ) specializes in the creation, manufacturing, and commercialization of stem cell-based therapies, utilizing mesenchymal stem cells to address critical, life-threatening illnesses. The company's primary therapeutic candidate, PulmoStem, is designed for the treatment of inflammatory and fibrotic conditions affecting the lungs. Furthermore, Amniotics is advancing other promising treatments such as CogniStem for neurological disorders, NephroStem for kidney-specific ailments, and CutiStem for various dermatological issues. Beyond its own pipeline, the firm provides contract development and manufacturing services for advanced therapy medicinal products to pharmaceutical companies, universities, and hospitals. Established in 2015, Amniotics AB is headquartered in Lund, Sweden.
Share Price
$0.00060315
Last synced: 2024-09-27
Market Cap
$1.65M
Change (1 day)
19.64%
Change (1 year)
0.00%
Country
SE
Trade Amniotics AB (publ) (AMNI)

Category

Stock split history for Amniotics AB (publ) (AMNI)
Amniotics AB (publ) stock (symbol: AMNI) underwent a total of 2 stock splits.
The most recent stock split occurred on Oct 06, 2023.
One AMNI share bought prior to Feb 20, 2023 would equal to 10.25586 AMNI shares today.
Stock split list
Year Split Multiple Cumulative Multiple
2023-10-06 681:200 x3.405 x10.25586
2023-02-20 753:250 x3.012 x3.012
Stock splits for similar companies or competitors
Company Number of stock splits Cumulative Multiple Country
1 x2
US
0 -
NL
0 -
CH
0 -
KR
0 -
BE